Blood pressure drugs recalled…again
Another week brings another blood pressure medication recall. The U.S. Food and Drug Administration has issued a recall of Torrent Pharmaceuticals Limited’s Losartan Potassium tablets. According to the FDA, “several batches” of the high pressure medication have been recalled.
N-Methylnitrosobutyric acid is the carcinogen detected in the tablets, though for what it’s worth, only “trace amounts” of the carcinogen were detected. According to the FDA, Losartan Potassium tablets are prescribed to patients suffering from hypertension, as well as “hypertensive patients with Left Ventricular Hypertrophy, and for the treatment of nephropathy in Type 2 diabetic patients…”
Recalled Torrent Pharmaceuticals Limited medications:
Losartan Potassium Tablets, USP 50mg, 1000 count
Batch No.: 4DU2E009
Losartan Potassium Tablets, USP 100mg, 90 count
Batch No.: 4DU3E009
Losartan Potassium Tablets, USP 100mg, 1000 count
Batch No.: 4DU3D018
Losartan Potassium / Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 count
Batch No.: BEF7D051
Losartan Potassium / Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 count
Batch No.: 4P04D007
Do not stop taking your prescribed blood pressure medications until speaking with your medical provider. If you’ve been prescribed blood pressure medication from Torrent Pharmaceuticals and experience any symptoms of carcinogen exposure, you should contact your medical care provider and Torrent Pharmaceuticals. Torrent can be reached by phone at 1-800-912-9561.
For more on this from CBS New York, click here: https://cbsloc.al/2ktE3O3